Precise, reproducible, and regulatory-ready: CE-based methods are redefining how scientists characterize therapeutic mAbs and ADCs across the biotherapeutic development pipeline.
This infographic provides industry professionals and senior scientists with insights into detailed methodologies for addressing stability challenges in protein therapeutics.
